TELA TELA Bio, Inc. - Common stock
$0.69
가격 · 8월 18, 2026
기준 재무 정보 8월 11, 2026
52주 범위
$1–$2
12% of range
애널리스트 평점
BUY
11 analysts
목표 주가
$2
+206% upside
P/E (TTM)
-0.8
ROE
-501.1%
순이익률
-48.4%
TELA 주식 스냅샷 가격, 시가총액, P/E, EPS, ROE, 부채/자본, 52주 범위
가격
$0.69
시가총액
$31M
P/E (TTM)
-0.8
EPS (TTM)
$-0.83
매출 (TTM)
$80M
배당 수익률
—
ROE
-501.1%
부채/자본
8.8
52주 범위
$1 – $2
TELA 주가 차트 기술 지표가 포함된 일일 OHLCV — 팬, 확대/축소 및 보기 사용자 정의
Configure
10년 성과 매출, 순이익, 마진 및 EPS 추세
매출 및 순이익
$80M
2017-12-31
→
2025-12-31
EPS
$-0.83
2019-12-31
→
2025-12-31
잉여현금흐름
$-29M
2019-12-31
→
2025-12-31
마진
-48.4%
2019-12-31
→
2025-12-31
가치 평가 P/E, P/S, P/B, EV/EBITDA 비율 — 주식이 비싼가요, 싼가요?
지표
5년 추세
TELA
동종업계 중앙값
P/E (TTM)
-0.8
15.4
P/S (TTM)
0.4
2.8
P/B
4.8
1.6
EV / EBITDA
-1.0
—
Price / FCF (주가 / FCF)
-1.1
—
수익성 총, 영업 및 순이익률; ROE, ROA, ROIC
지표
5년 추세
TELA
동종업계 중앙값
Gross Margin (매출 총이익률)
67.7%
31.6%
Operating Margin (영업이익률)
-42.0%
—
Net Profit Margin (순이익률)
-48.4%
-49.3%
ROA
-46.2%
-54.9%
ROE
-501.1%
-98.0%
ROIC
-54.8%
—
재무 건전성 부채, 유동성, 지급능력 — 대차대조표 건전성
지표
5년 추세
TELA
동종업계 중앙값
Debt / Equity (부채 / 자기자본 비율)
8.8
0.0
Current Ratio (유동비율)
4.2
4.7
Quick Ratio (당좌 비율)
3.4
—
성장 매출, EPS 및 순이익 성장률: YoY, 3년 CAGR, 5년 CAGR
지표
5년 추세
TELA
동종업계 중앙값
Revenue YoY (매출 YoY)
15.8%
—
Revenue CAGR 3Y (매출 CAGR 3년)
24.7%
—
Revenue CAGR 5Y (매출 CAGR 5년)
34.5%
—
자본 효율성 자산 회전율, 재고 회전율, 매출채권 회전율
지표
5년 추세
TELA
동종업계 중앙값
TELA 분석가 합의 강세 및 약세 애널리스트 의견, 12개월 목표 주가, 상승 여력
매수
11 명의 애널리스트
- 적극 매수 3 27.3%
- 매수 6 54.5%
- 보유 2 18.2%
- 매도 0 0.0%
- 적극 매도 0 0.0%
12개월 목표 주가
5 명의 애널리스트 · 2026-08-15
중앙값
$2.00
← 모든 목표가 하회
$0.69
저가
$1.00
고가
$3.00
중앙값 목표
$2.00
+191.5%
평균 목표
$2.10
+206.1%
실적 기록 EPS 실제 vs 예상, 서프라이즈 %, 달성률, 다음 실적 발표일
평균 서프라이즈
-0.01%
| 기간 | EPS Actual | EPS 예상 | 서프라이즈 |
|---|---|---|---|
| 2026년 6월 30일 | $-0.20 | $-0.18 | -0.02% |
| 2026년 3월 31일 | $-0.21 | $-0.19 | -0.02% |
| 2025년 12월 31일 | $-0.17 | $-0.19 | 0.02% |
| 2025년 9월 30일 | $-0.19 | $-0.20 | 0.01% |
| 2025년 6월 30일 | $-0.22 | $-0.18 | -0.04% |
| 2025년 3월 31일 | $-0.25 | $-0.20 | -0.05% |
| 2024년 12월 31일 | $-0.23 | $-0.23 | -0.00% |
동종 기업 비교(GICS 하위 산업) 주요 지표 대 섹터 동종 기업
| 티커 | 시가총액 | P/E | 매출 YoY | 순이익률 | ROE | 매출 총이익률 |
|---|---|---|---|---|---|---|
| TELA | $53M | -1.4 | 15.8% | -48.4% | -501.1% | 67.7% |
| UTMD | $178M | 16.1 | -5.8% | 29.3% | 9.5% | 57.1% |
| NSPR | $77M | -2.3 | 28.1% | -543.3% | -129.3% | 29.5% |
| RMTI | $33M | -5.5 | -31.8% | -7.7% | -15.8% | 16.9% |
| ADVB | $15M | -4.4 | — | — | -159.1% | — |
전체 기본 지표 연도별 모든 지표 — 손익계산서, 대차대조표, 현금흐름
손익계산서 16
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $80M | $69M | $58M | $41M | $29M | $18M | $15M | $8M | |
| Gross Profit | $54M | $46M | $40M | $27M | $19M | $11M | $9M | $3M | |
| R&D Expense | $9M | $9M | $10M | $9M | $7M | $4M | $4M | $4M | |
| SG&A Expense | $16M | $15M | $15M | $14M | $12M | $10M | $6M | $5M | |
| Operating Expenses | $88M | $88M | $84M | $66M | $48M | $37M | $28M | $21M | |
| Operating Income | $-34M | $-34M | $-44M | $-39M | $-29M | $-25M | $-19M | $-18M | |
| Interest Expense | · | · | $5M | $4M | $4M | $4M | $4M | $2M | |
| Other Non-op | $1M | $1M | $3M | $-10.0K | $-228.0K | $45.0K | $351.0K | $70.0K | |
| Pretax Income | $-39M | $-38M | $-47M | $-44M | · | · | · | · | |
| Income Tax | $230.0K | $-144.0K | · | · | · | · | · | · | |
| Net Income | $-39M | $-38M | $-47M | $-44M | $-33M | $-29M | $-22M | $-21M | |
| EPS (Basic) | $-0.83 | $-1.33 | $-2.04 | $-2.72 | $-2.30 | $-2.23 | $-17.10 | · | |
| EPS (Diluted) | $-0.83 | $-1.33 | $-2.04 | $-2.72 | $-2.30 | $-2.23 | $-17.10 | · | |
| Shares (Basic) | 46,947,932 | 28,526,441 | 22,868,663 | 16,267,678 | 14,473,213 | 12,934,421 | 1,766,412 | · | |
| Shares (Diluted) | 46,947,932 | 28,526,441 | 22,868,663 | 16,267,678 | 14,473,213 | 12,934,421 | 1,766,412 | · | |
| EBITDA | $-34M | $-34M | $-44M | $-39M | $-29M | $-25M | $-19M | · |
대차대조표 27
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $51M | $53M | $47M | $42M | $44M | $74M | $45M | $17M | |
| Short-term Investments | · | · | · | · | · | $0 | $9M | · | |
| Receivables | $10M | $10M | $10M | $7M | $4M | $3M | $3M | $1M | |
| Inventory | $11M | $13M | $13M | $12M | $8M | $4M | $5M | $4M | |
| Prepaid Expense | $3M | $3M | $2M | $2M | $3M | $2M | $2M | $330.0K | |
| Current Assets | $76M | $78M | $72M | $62M | $59M | $83M | $64M | $23M | |
| PP&E (Net) | $2M | $2M | $2M | $2M | $1M | $626.0K | $677.0K | $758.0K | |
| PP&E (Gross) | $6M | $7M | $6M | $6M | $5M | $4M | $4M | $4M | |
| Accum. Depreciation | $3M | $5M | $4M | $4M | $4M | $4M | $4M | $3M | |
| Intangibles | $1M | $2M | $2M | $2M | $2M | $3M | $3M | · | |
| Other Non-current Assets | $500.0K | $2M | · | · | · | · | · | · | |
| Total Assets | $81M | $87M | $78M | $68M | $63M | $86M | $68M | $27M | |
| Accounts Payable | $2M | $2M | $2M | $2M | $2M | $652.0K | $3M | $3M | |
| Accrued Liabilities | $16M | $13M | $15M | $11M | $8M | $6M | $4M | $5M | |
| Current Liabilities | $18M | $16M | $17M | $12M | $11M | $7M | $7M | $10M | |
| Capital Leases | · | $2M | $2M | $1M | · | · | · | · | |
| Other Non-current Liabilities | $1M | $1M | $2M | $1M | $380.0K | · | $4.0K | $5.0K | |
| Total Liabilities | $75M | $58M | $59M | $54M | $42M | $37M | $37M | $41M | |
| Long-term Debt | · | $41M | $41M | $40M | $31M | $31M | $30M | · | |
| Total Debt | $56M | $41M | $41M | $40M | · | · | · | · | |
| Common Stock | $44.0K | $39.0K | $24.0K | $19.0K | $15.0K | $14.0K | $11.0K | · | |
| Paid-in Capital | $404M | $387M | $340M | $288M | $250M | $246M | $199M | · | |
| Retained Earnings | $-398M | $-359M | $-321M | $-274M | $-230M | $-197M | $-168M | $-138M | |
| AOCI | $91.0K | $90.0K | $91.0K | $150.0K | $-52.0K | $-71.0K | $-19.0K | · | |
| Stockholders' Equity | $6M | $28M | $19M | $14M | $20M | $49M | $31M | $-138M | |
| Liabilities + Equity | $81M | $87M | $78M | $68M | $63M | $86M | $68M | $27M | |
| Shares Outstanding | 44,538,264 | 39,395,712 | 24,494,675 | 19,165,027 | 14,529,577 | 14,437,107 | 11,406,221 | 295,717 |
현금 흐름 13
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $4M | $4M | $5M | $4M | $4M | $2M | $457.0K | $216.0K | |
| Deferred Tax | $144.0K | $-144.0K | · | · | · | · | · | · | |
| Operating Cash Flow | $-28M | $-42M | $-41M | $-41M | $-30M | $-24M | $-26M | $-20M | |
| CapEx | $448.0K | $989.0K | $611.0K | $872.0K | $627.0K | $167.0K | $197.0K | $62.0K | |
| Investing Cash Flow | $846.0K | $4M | $-599.0K | $-2M | $-627.0K | $9M | $-12M | $-2M | |
| Debt Issued | · | · | · | $40M | · | · | · | · | |
| Net Debt Issued | $-42M | · | · | $10M | · | · | · | · | |
| Stock Issued | · | · | $46M | $34M | · | $45M | · | · | |
| Net Stock Activity | · | · | $46M | $34M | · | $34.0K | · | · | |
| Financing Cash Flow | $26M | $43M | $46M | $41M | $585.0K | $44M | $66M | $27M | |
| Net Change in Cash | $-2M | $6M | $5M | $-2M | $-30M | $29M | $28M | $6M | |
| Taxes Paid | $0 | · | · | · | · | · | · | · | |
| Free Cash Flow | $-29M | $-43M | $-41M | $-42M | $-31M | $-25M | $-26M | · |
수익성 8
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 67.7% | 67.1% | 68.6% | 65.3% | 63.8% | 61.7% | 60.0% | · | |
| Operating Margin | -42.0% | -49.2% | -75.4% | -94.2% | -100.0% | -138.8% | -124.1% | · | |
| Net Margin | -48.4% | -54.6% | -79.8% | -106.9% | -112.9% | -158.1% | -145.2% | · | |
| Pretax Margin | -48.1% | -54.8% | · | · | · | · | · | · | |
| EBITDA Margin | -42.0% | -49.2% | -75.4% | -94.2% | -100.0% | -138.8% | -124.1% | · | |
| ROA | -46.2% | -46.0% | -64.0% | -67.9% | -44.7% | -37.3% | -47.1% | · | |
| ROE | -501.1% | -341.1% | -188.8% | -235.6% | -139.2% | -54.7% | 34.6% | · | |
| ROIC | -54.8% | -48.8% | · | · | · | · | · | · |
유동성 및 지급능력 5
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.2 | 5.0 | 4.2 | 5.0 | 5.6 | 12.6 | 9.6 | · | |
| Quick Ratio | 3.4 | 4.0 | 3.3 | 3.9 | 4.6 | 11.7 | 8.6 | · | |
| Debt / Equity | 8.8 | 1.4 | 2.1 | 2.8 | · | · | · | · | |
| LT Debt / Equity | 8.8 | 1.4 | 2.1 | 2.8 | · | · | · | · | |
| Interest Coverage | · | · | -8.4 | -9.6 | -8.2 | -7.1 | -5.3 | · |
효율성 2
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.0 | 0.8 | 0.8 | 0.6 | 0.4 | 0.2 | 0.3 | · | |
| Receivables Turnover | 7.9 | 7.0 | 7.1 | 7.6 | 8.5 | 6.6 | 7.5 | · |
성장률 3
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 15.8% | 18.6% | 41.1% | 40.6% | 61.8% | · | · | · | |
| Revenue CAGR 3Y | 24.7% | 33.0% | 47.5% | · | · | · | · | · | |
| Revenue CAGR 5Y | 34.5% | · | · | · | · | · | · | · |
가치 평가 (TTM) 14
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $80M | $69M | $58M | $41M | $29M | $18M | $15M | · | |
| Net Income TTM | $-39M | $-38M | $-47M | $-44M | $-33M | $-29M | $-22M | · | |
| Market Cap | $53M | $119M | $162M | $220M | $186M | $217M | $148M | · | |
| Enterprise Value | $57M | $107M | $156M | $218M | · | · | · | · | |
| P/E | -1.4 | -2.3 | -3.2 | -4.2 | -5.6 | -6.7 | -0.8 | · | |
| P/S | 0.7 | 1.7 | 2.8 | 5.3 | 6.3 | 11.9 | 9.6 | · | |
| P/B | 8.3 | 4.2 | 8.6 | 15.4 | 9.3 | 4.4 | 4.8 | · | |
| P / Tangible Book | 10.6 | 4.5 | 9.7 | 18.7 | 10.5 | 4.7 | · | · | |
| P / Cash Flow | -1.9 | -2.9 | -4.0 | -5.4 | -6.1 | -8.9 | -5.8 | · | |
| P / FCF | -1.8 | -2.8 | -3.9 | -5.3 | -6.0 | -8.8 | -5.7 | · | |
| EV / EBITDA | -1.7 | -3.1 | -3.5 | -5.6 | · | · | · | · | |
| EV / FCF | -2.0 | -2.5 | -3.8 | -5.2 | · | · | · | · | |
| EV / Revenue | 0.7 | 1.6 | 2.7 | 5.3 | · | · | · | · | |
| Earnings Yield | -70.3% | -44.0% | -30.8% | -23.6% | -18.0% | -14.8% | -132.1% | · |
손익계산서 16
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $19M | $19M | $21M | $21M | $20M | $19M | $18M | $19M | $16M | $17M | $17M | $15M | $14M | $12M | $12M | $11M | |
| Gross Profit | $14M | $13M | $14M | $14M | $14M | $13M | $11M | $13M | $11M | $11M | $12M | $10M | $10M | $8M | $8M | $7M | |
| R&D Expense | $3M | $2M | $2M | $2M | $2M | $3M | $2M | $2M | $2M | $2M | $3M | $2M | $3M | $2M | $3M | $2M | |
| SG&A Expense | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $3M | $4M | $3M | $4M | |
| Operating Expenses | $23M | $23M | $20M | $22M | $23M | $23M | $20M | $22M | $23M | $24M | $24M | $21M | $21M | $19M | $18M | $17M | |
| Operating Income | $-9M | $-11M | $-7M | $-8M | $-9M | $-10M | $-8M | $-9M | $-12M | $-5M | $-12M | $-10M | $-10M | $-11M | $-9M | $-9M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $1M | · | $1M | $1M | $1M | · | $1M | |
| Other Non-op | $157.0K | $366.0K | $277.0K | $152.0K | $379.0K | $479.0K | $285.0K | $337.0K | $301.0K | $497.0K | $733.0K | $558.0K | $870.0K | $473.0K | $634.0K | $-195.0K | |
| Pretax Income | $-11M | $-12M | $-9M | $-9M | $-10M | $-11M | $-9M | $-10M | $-13M | $-6M | · | · | · | · | · | · | |
| Income Tax | $60.0K | $60.0K | $145.0K | $0 | $33.0K | $52.0K | · | · | · | · | · | · | · | · | · | · | |
| Net Income | $-11M | $-12M | $-9M | $-9M | $-10M | $-11M | $-9M | $-10M | $-13M | $-6M | $-13M | $-11M | $-11M | $-12M | $-10M | $-11M | |
| EPS (Basic) | $-0.20 | $-0.21 | $-0.17 | $-0.19 | $-0.22 | $-0.25 | $-0.17 | $-0.42 | $-0.51 | $-0.23 | $-0.50 | $-0.45 | $-0.46 | $-0.63 | $-0.45 | $-0.64 | |
| EPS (Diluted) | $-0.20 | $-0.21 | $-0.17 | $-0.19 | $-0.22 | $-0.25 | $-0.17 | $-0.42 | $-0.51 | $-0.23 | $-0.50 | $-0.45 | $-0.46 | $-0.63 | $-0.45 | $-0.64 | |
| Shares (Basic) | 57,414,360 | 57,256,518 | -89,106,208 | 45,421,795 | 45,365,325 | 45,267,020 | -45,419,757 | 24,703,578 | 24,663,234 | 24,579,386 | -44,039,884 | 24,483,664 | 23,239,262 | 19,185,621 | -29,587,212 | 16,758,573 | |
| Shares (Diluted) | 57,414,360 | 57,256,518 | -89,106,208 | 45,421,795 | 45,365,325 | 45,267,020 | -45,419,757 | 24,703,578 | 24,663,234 | 24,579,386 | -44,039,884 | 24,483,664 | 23,239,262 | 19,185,621 | -29,587,212 | 16,758,573 | |
| EBITDA | $-9M | $-11M | · | $-8M | $-9M | $-10M | · | $-9M | $-12M | $-5M | · | $-10M | $-10M | $-11M | · | $-9M |
대차대조표 26
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $30M | $40M | $51M | $30M | $35M | $43M | $53M | $17M | $26M | $37M | · | $58M | $65M | $30M | · | $54M | |
| Receivables | $10M | $10M | $10M | $11M | $11M | $11M | $10M | $11M | $9M | $10M | · | $8M | $8M | $7M | · | $6M | |
| Inventory | $11M | $12M | $11M | $12M | $11M | $14M | $13M | $14M | $13M | $14M | · | $14M | $14M | $15M | · | $12M | |
| Prepaid Expense | $3M | $3M | $3M | $4M | $3M | $3M | $3M | $2M | $2M | $2M | · | $2M | $2M | $2M | · | $2M | |
| Current Assets | $54M | $64M | $76M | $56M | $61M | $70M | $78M | $44M | $51M | $63M | · | $82M | $89M | $54M | · | $74M | |
| PP&E (Net) | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | $2M | $2M | $2M | · | $2M | |
| PP&E (Gross) | · | · | $6M | · | · | · | $7M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $3M | · | · | · | $5M | · | · | · | · | · | · | · | · | · | |
| Intangibles | $1M | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | · | $2M | $2M | $2M | · | $3M | |
| Other Non-current Assets | $451.0K | $476.0K | $500.0K | · | $1M | $2M | $2M | $3M | $3M | $3M | · | · | · | · | · | · | |
| Total Assets | $60M | $70M | $81M | $62M | $68M | $77M | $87M | $53M | $60M | $72M | · | $87M | $94M | $59M | · | $80M | |
| Accounts Payable | $3M | $4M | $2M | $2M | $2M | $4M | $2M | $2M | $2M | $3M | · | $3M | $2M | $5M | · | $5M | |
| Accrued Liabilities | $15M | $14M | $16M | $15M | $14M | $13M | $13M | $14M | $13M | $12M | · | $12M | $11M | $9M | · | $10M | |
| Current Liabilities | $18M | $18M | $18M | $17M | $19M | $17M | $16M | $17M | $15M | $15M | · | $15M | $13M | $14M | · | $15M | |
| Capital Leases | · | · | · | · | · | · | $2M | · | · | · | · | $1M | $1M | $1M | · | $1M | |
| Other Non-current Liabilities | $1M | $1M | $1M | $2M | $1M | $1M | $1M | $1M | $2M | $2M | · | $1M | $1M | $1M | · | $1M | |
| Total Liabilities | $76M | $75M | $75M | $60M | $58M | $59M | $58M | $59M | $57M | $57M | · | $57M | $54M | $56M | · | $56M | |
| Long-term Debt | · | · | · | · | $41M | $41M | · | $41M | $41M | $41M | · | $40M | $40M | $40M | · | $40M | |
| Total Debt | $56M | $56M | · | $41M | $41M | $41M | · | $41M | $41M | $41M | · | $40M | $40M | $40M | · | $40M | |
| Common Stock | $45.0K | $45.0K | $44.0K | $40.0K | $40.0K | $40.0K | $39.0K | $25.0K | $25.0K | $25.0K | · | $24.0K | $24.0K | $19.0K | · | $19.0K | |
| Paid-in Capital | $405M | $405M | $404M | $390M | $389M | $388M | $387M | $343M | $342M | $341M | · | $338M | $337M | $289M | · | $287M | |
| Retained Earnings | $-421M | $-410M | $-398M | $-389M | $-380M | $-370M | $-359M | $-350M | $-339M | $-327M | · | $-308M | $-297M | $-286M | · | $-264M | |
| AOCI | $84.0K | $85.0K | $91.0K | $91.0K | $93.0K | $91.0K | $90.0K | $149.0K | $98.0K | $97.0K | · | $135.0K | $84.0K | $120.0K | · | $262.0K | |
| Stockholders' Equity | $-16M | $-5M | $6M | $2M | $9M | $18M | $28M | $-6M | $3M | $14M | $19M | $31M | $40M | $3M | $14M | $23M | |
| Liabilities + Equity | $60M | $70M | $81M | $62M | $68M | $77M | $87M | $53M | $60M | $72M | · | $87M | $94M | $59M | · | $80M | |
| Shares Outstanding | 44,833,942 | 44,765,928 | 44,538,264 | 40,341,535 | 39,584,178 | 39,554,771 | 39,395,712 | 24,717,193 | 24,675,832 | 24,653,939 | · | 24,487,578 | 24,475,504 | 19,227,777 | · | 19,159,145 |
현금 흐름 10
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $613.0K | $816.0K | $812.0K | $955.0K | $985.0K | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| Deferred Tax | · | · | $59.0K | $0 | $33.0K | $52.0K | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-9M | $-11M | $-5M | $-6M | $-8M | $-10M | $-8M | $-9M | $-11M | $-14M | $-11M | $-7M | $-11M | $-12M | $-11M | $-8M | |
| CapEx | $59.0K | $119.0K | $91.0K | $211.0K | $114.0K | $32.0K | $264.0K | $122.0K | $299.0K | $304.0K | $205.0K | $134.0K | $157.0K | $115.0K | $46.0K | $290.0K | |
| Investing Cash Flow | $239.0K | $190.0K | $192.0K | $312.0K | $204.0K | $138.0K | $-190.0K | $-122.0K | $67.0K | $5M | $-193.0K | $-134.0K | $-157.0K | $-115.0K | $-1M | $-290.0K | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | · | $-13.0K | · | · | · | · | |
| Financing Cash Flow | $-15.0K | $-298.0K | $26M | $24.0K | $-3.0K | $-116.0K | $43M | $98.0K | $-5.0K | $56.0K | $22.0K | $71.0K | $46M | $-235.0K | $-219.0K | $35M | |
| Net Change in Cash | $-9M | $-11M | $21M | $-5M | $-8M | $-10M | $35M | $-9M | $-11M | $-10M | $-11M | $-7M | $35M | $-12M | $-12M | $27M | |
| Free Cash Flow | · | $-11M | · | · | · | $-10M | · | · | · | $-15M | · | · | · | $-12M | · | · |
수익성 8
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 72.3% | 65.7% | · | 67.5% | 69.8% | 67.6% | · | 67.8% | 68.8% | 68.3% | · | 69.0% | 70.4% | 66.3% | · | 65.6% | |
| Operating Margin | -48.1% | -55.2% | · | -36.5% | -45.0% | -56.5% | · | -49.4% | -71.9% | -29.1% | · | -67.6% | -71.5% | -94.5% | · | -85.0% | |
| Net Margin | -58.4% | -64.4% | · | -41.6% | -49.1% | -60.8% | · | -54.7% | -78.3% | -34.1% | · | -72.8% | -74.4% | -101.0% | · | -96.0% | |
| Pretax Margin | -58.1% | -64.1% | · | -41.6% | -49.0% | -60.5% | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -48.1% | -55.2% | · | -36.5% | -45.0% | -56.5% | · | -49.4% | -71.9% | -29.1% | · | -67.6% | -71.5% | -94.5% | · | -85.0% | |
| ROA | -17.7% | -16.7% | · | -15.0% | -15.5% | -15.1% | · | -14.8% | -16.3% | -8.7% | · | -13.1% | -14.8% | -21.1% | · | -14.4% | |
| ROE | 337.1% | -190.0% | · | 364.9% | -164.6% | -69.3% | · | -85.4% | -58.8% | -64.6% | · | -40.7% | -56.1% | -182.5% | · | -42.0% | |
| ROIC | -23.2% | -20.9% | · | · | -18.0% | -17.7% | · | · | · | · | · | · | · | · | · | · |
유동성 및 지급능력 5
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.0 | 3.6 | · | 3.3 | 3.2 | 4.2 | · | 2.6 | 3.4 | 4.1 | · | 5.4 | 6.8 | 3.7 | · | 4.9 | |
| Quick Ratio | 2.2 | 2.8 | · | 2.4 | 2.4 | 3.2 | · | 1.7 | 2.4 | 3.1 | · | 4.3 | 5.6 | 2.6 | · | 3.9 | |
| Debt / Equity | -3.5 | -10.7 | · | 26.6 | 4.5 | 2.3 | · | -6.5 | 14.2 | 2.8 | · | 1.3 | 1.0 | 12.8 | · | 1.7 | |
| LT Debt / Equity | -3.5 | -10.7 | · | 26.6 | 4.1 | 2.3 | · | -6.5 | 14.2 | 2.8 | · | 1.3 | 1.0 | 12.8 | · | 1.7 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -3.6 | · | -7.6 | -8.0 | -9.0 | · | -9.2 |
효율성 2
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | · | 0.4 | 0.3 | 0.2 | · | 0.3 | 0.2 | 0.3 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | |
| Receivables Turnover | 1.8 | 1.9 | · | 1.8 | 2.0 | 1.8 | · | 2.0 | 1.9 | 2.0 | · | 2.2 | 2.2 | 2.2 | · | 2.4 |
가치 평가 (TTM) 14
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $79M | $78M | · | $78M | $74M | $70M | · | $67M | $62M | $58M | · | $53M | $48M | $42M | · | $37M | |
| Net Income TTM | $-42M | $-42M | · | $-40M | $-44M | $-40M | · | $-40M | $-40M | $-39M | · | $-44M | $-46M | $-46M | · | $-43M | |
| Market Cap | $34M | $28M | · | $60M | $77M | $48M | · | $63M | $116M | $140M | · | $196M | $248M | $205M | · | $163M | |
| Enterprise Value | $59M | $44M | · | $72M | $83M | $47M | · | $86M | $130M | $143M | · | $178M | $223M | $215M | · | $149M | |
| P/E | -0.9 | -0.7 | · | -1.4 | -1.4 | -0.9 | · | -1.6 | -2.8 | -3.2 | · | -3.7 | -3.9 | -3.7 | · | -3.0 | |
| P/S | 0.4 | 0.4 | · | 0.8 | 1.0 | 0.7 | · | 0.9 | 1.9 | 2.4 | · | 3.7 | 5.2 | 4.9 | · | 4.4 | |
| P/B | -2.1 | -5.3 | · | 38.6 | 8.4 | 2.7 | · | -10.0 | 40.4 | 9.7 | · | 6.4 | 6.2 | 65.1 | · | 7.0 | |
| P / Tangible Book | · | · | · | 583.6 | 10.1 | 2.9 | · | · | 123.2 | 11.3 | · | 6.9 | 6.6 | 277.6 | · | 7.9 | |
| P / Cash Flow | · | -2.5 | · | · | · | -5.0 | · | · | · | -9.7 | · | · | · | -17.7 | · | · | |
| P / FCF | · | -2.5 | · | · | · | -4.9 | · | · | · | -9.5 | · | · | · | -17.5 | · | · | |
| EV / EBITDA | -6.4 | -4.2 | · | -9.5 | -9.2 | -4.5 | · | -9.2 | -11.3 | -29.7 | · | -17.5 | -21.5 | -19.1 | · | -15.7 | |
| EV / FCF | · | -3.9 | · | · | · | -4.8 | · | · | · | -9.8 | · | · | · | -18.4 | · | · | |
| EV / Revenue | 0.7 | 0.6 | · | 0.9 | 1.1 | 0.7 | · | 1.3 | 2.1 | 2.5 | · | 3.4 | 4.6 | 5.1 | · | 4.0 | |
| Earnings Yield | -109.3% | -140.3% | · | -72.5% | -72.2% | -115.6% | · | -63.6% | -35.1% | -31.2% | · | -27.3% | -25.8% | -27.3% | · | -33.3% |
재무제표 손익계산서, 대차대조표, 현금흐름 — 연간, 지난 5년
손익계산서
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 매출 | $80M | $69M | $58M | $41M | $29M |
| 매출 총이익률 % | 67.7% | 67.1% | 68.6% | 65.3% | 63.8% |
| 영업이익률 % | -42.0% | -49.2% | -75.4% | -94.2% | -100.0% |
| 순이익 | $-39M | $-38M | $-47M | $-44M | $-33M |
| 희석 EPS | $-0.83 | $-1.33 | $-2.04 | $-2.72 | $-2.30 |
대차대조표
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 부채 / 자기자본 비율 | 8.8 | 1.4 | 2.1 | 2.8 | — |
| 유동비율 | 4.2 | 5.0 | 4.2 | 5.0 | 5.6 |
| 당좌 비율 | 3.4 | 4.0 | 3.3 | 3.9 | 4.6 |
현금 흐름
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 잉여현금흐름 | $-29M | $-43M | $-41M | $-42M | $-31M |
나의 지표 나만의 관심 목록 — 전체 기본 재무제표에서 선택한 항목
📊
중요한 지표를 선택하세요 — 위 전체 기본 재무제표의 아무 행 옆에 있는 ➕를 클릭하세요.
선택 항목이 저장되어 모든 티커에서 유지됩니다.
기관 투자자 (13F) 46개의 제출자 · $19.3M 전체 · 기준일 2026년 6월 30일
분기별 SEC 양식 13F에서 이 주식을 보유하고 있다고 보고하는 기관. 롱 포지션만 해당하며, 단일 제출자는 별도의 옵션 레그에 대해 두 번 나타날 수 있습니다. 대규모 상쇄 풋/콜 포지션은 일반적으로 방향성에 대한 확신보다는 시장 조성 또는 헤지된 재고를 반영합니다.
기관 활동 — Q2 2026 대 이전 분기
| 신규 포지션 | 청산 포지션 | 증가함 | 감소 | 순주식 변동 |
|---|---|---|---|---|
| 13 (+12 이전 분기 대비) | 1 (-8 이전 분기 대비) | 9 (-3 이전 분기 대비) | 9 (+4 이전 분기 대비) | -65K |
Q1 2026 대비 비교. SEC 양식 13F 제출은 분기 말로부터 45일 이내에 마감되며, 지연 제출자를 위한 짧은 유예 기간이 추가됩니다. 해당 기간 내에 있는 분기는 가장 최근에 완전히 보고된 쌍을 선호하여 건너뜁니다.
| 기관 | 가치 | 주식 | % 추적된 13F 중 | 유형 |
|---|---|---|---|---|
| Essex Woodlands Management, Inc. | $5,786,032 | 7,714,709 | 30.04% | 주식 |
| Nantahala Capital Management, LLC | $4,420,586 | 5,894,114 | 22.95% | 주식 |
| Stonepine Capital Management, LLC | $1,996,820 | 2,662,427 | 10.37% | 주식 |
| SILVERARC CAPITAL MANAGEMENT, LLC | $1,602,901 | 2,137,201 | 8.32% | 주식 |
| VANGUARD CAPITAL MANAGEMENT LLC | $1,176,164 | 1,568,218 | 6.11% | 주식 |
| DAFNA Capital Management LLC | $1,080,772 | 1,441,029 | 5.61% | 주식 |
| PERKINS CAPITAL MANAGEMENT INC | $1,031,281 | 1,375,042 | 5.35% | 주식 |
| Sio Capital Management, LLC | $477,225 | 636,300 | 2.48% | 주식 |
| WealthTrust Axiom LLC | $343,300 | 457,734 | 1.78% | 주식 |
| VANGUARD GROUP INC | $249,761 | 211,662 | 1.30% | 주식 |
| GEODE CAPITAL MANAGEMENT, LLC | $243,264 | 324,305 | 1.26% | 주식 |
| VANGUARD FIDUCIARY TRUST CO | $159,854 | 213,138 | 0.83% | 주식 |
| UP STRATEGIC WEALTH INVESTMENT ADVISORS LLC | $91,398 | 99,888 | 0.47% | 주식 |
| Embree Financial Group | $68,180 | 90,906 | 0.35% | 주식 |
| BlackRock, Inc. | $63,547 | 84,729 | 0.33% | 주식 |
| NORTHERN TRUST CORP | $56,093 | 74,790 | 0.29% | 주식 |
| STATE STREET CORP | $47,537 | 63,383 | 0.25% | 주식 |
| RENAISSANCE TECHNOLOGIES LLC | $43,575 | 58,100 | 0.23% | 주식 |
| PNC Financial Services Group, Inc. | $40,209 | 53,612 | 0.21% | 주식 |
| Destiny Wealth Partners, LLC | $38,320 | 52,500 | 0.20% | 주식 |
| Ducere Wealth Management LLC | $38,250 | 51,000 | 0.20% | 주식 |
| JANE STREET GROUP, LLC | $26,470 | 35,294 | 0.14% | 주식 |
| UBS Group AG | $25,100 | 33,466 | 0.13% | 주식 |
| XTX Topco Ltd | $22,169 | 29,558 | 0.12% | 주식 |
| TD Waterhouse Canada Inc. | $16,560 | 23,000 | 0.09% | 주식 |
| PRIMORIS WEALTH ADVISORS, LLC | $15,225 | 20,300 | 0.08% | 주식 |
| RAYMOND JAMES FINANCIAL INC | $15,000 | 20,000 | 0.08% | 주식 |
| GREAT VALLEY ADVISOR GROUP, INC. | $14,702 | 19,602 | 0.08% | 주식 |
| J.W. COLE ADVISORS, INC. | $12,188 | 16,250 | 0.06% | 주식 |
| Atom Investors LP | $11,605 | 15,473 | 0.06% | 주식 |
| MERCER GLOBAL ADVISORS INC /ADV | $11,121 | 14,828 | 0.06% | 주식 |
| HighTower Advisors, LLC | $8,400 | 11,200 | 0.04% | 주식 |
| GOLDMAN SACHS GROUP INC | $7,787 | 10,383 | 0.04% | 주식 |
| Tower Research Capital LLC (TRC) | $7,691 | 10,255 | 0.04% | 주식 |
| Vanguard Global Advisers, LLC | $3,453 | 4,604 | 0.02% | 주식 |
| WELLS FARGO & COMPANY/MN | $3,150 | 4,200 | 0.02% | 주식 |
| Steward Partners Investment Advisory, LLC | $1,493 | 1,991 | 0.01% | 주식 |
| CITIGROUP INC | $1,331 | 1,774 | 0.01% | 주식 |
| SIMPLEX TRADING, LLC | $957 | 1,276 | 0.00% | 주식 |
| SBI Securities Co., Ltd. | $226 | 301 | 0.00% | 주식 |
| BNP PARIBAS FINANCIAL MARKETS | $158 | 210 | 0.00% | 주식 |
| BARCLAYS PLC | $156 | 208 | 0.00% | 주식 |
| OSAIC HOLDINGS, INC. | $75 | 100 | 0.00% | 주식 |
| JPMORGAN CHASE & CO | $28 | 39 | 0.00% | 주식 |
| MORGAN STANLEY | $28 | 37 | 0.00% | 주식 |
| ROYAL BANK OF CANADA | $0 | 59 | 0.00% | 주식 |
회사 내부자 26 명의 내부자 · 10 임원 · 16 이사
| 내부자 | 역할 | 마지막 활동 | 보유 주식 수 | 매수 12개월 | 매도 12개월 | 순매수/매도 12개월 |
|---|---|---|---|---|---|---|
| Antony Koblish | Chief Executive Officer | 2026년 2월 20일 A | 586,210 | 0 | 0 | $0 |
| Roberto Cuca | COO and CFO | 2025년 2월 21일 A | 208,233 | 0 | 0 | $0 |
| Nora Brennan | Chief Financial Officer | 2021년 3월 31일 A | 17,696 | 0 | 0 | $0 |
| Jeffrey Blizard | President | 2025년 6월 2일 A | 119,125 | 0 | 0 | $0 |
| Gregory A. Firestone | Chief Commercial Officer | 2025년 8월 3일 F | 106,790 | 0 | 0 | $0 |
| Megan Smeykal | Chief Accounting Officer | 2025년 3월 31일 F | 36,831 | 0 | 0 | $0 |
| Paul Talmo | Chief Technology Officer | 2025년 3월 31일 F | 123,882 | 0 | 0 | $0 |
| Peter C. Murphy | Chief Commercial Officer | 2024년 3월 31일 F | 48,129 | 0 | 0 | $0 |
| Ellis Skott Greenhalgh | Chief Technology Officer | 2022년 2월 24일 F | 27,826 | 0 | 0 | $0 |
| Maarten Persenaire | Chief Medical Officer | 2021년 2월 24일 A | 90,887 | 0 | 0 | $0 |
| William J. Plovanic | 이사 | 2026년 7월 15일 A | 44,530 | 0 | 0 | $0 |
| Joseph H Capper | 이사 | 2026년 7월 15일 A | 29,827 | 0 | 0 | $0 |
| Betty Jo Rocchio | 이사 | 2026년 6월 9일 A | 23,600 | 0 | 0 | $0 |
| Guido J Neels | 이사 | 2026년 6월 9일 A | 23,600 | 0 | 0 | $0 |
| Guy P Nohra | 이사 | 2026년 6월 9일 A | 23,600 | 0 | 0 | $0 |
| Paul Thomas | 이사 | 2026년 6월 9일 A | 23,600 | 0 | 0 | $0 |
| Kurt Azarbarzin | 이사 | 2025년 5월 28일 A | 18,470 | 0 | 0 | $0 |
| Vincent J Burgess | 이사 | 2025년 5월 28일 A | 23,330 | 0 | 0 | $0 |
| Douglas G Evans | 이사 | 2025년 5월 28일 A | 18,470 | 0 | 0 | $0 |
| Lisa N Colleran | 이사 | 2025년 5월 28일 A | 18,470 | 0 | 0 | $0 |
| Federica F. O'Brien | 이사 | 2025년 5월 28일 A | 18,470 | 0 | 0 | $0 |
| John Nosenzo | 이사 | 2023년 6월 1일 A | 6,270 | 0 | 0 | $0 |
| Adele C Oliva | 이사 | 2020년 6월 4일 A | 1,751,100 | 0 | 0 | $0 |
| Matt Zuga | 이사 | 2019년 11월 13일 C | 498,606 | 0 | 0 | $0 |
| Ashley Friedman | 이사 | 2019년 11월 13일 C | 505,281 | 0 | 0 | $0 |
| Heather C Getz | — | 2026년 8월 14일 P | 520,000 | 1 | 0 | $10,500 |
SEC 양식 3/4/5 제출 서류 기준 내부자; 순매수/매도는 공개 시장 거래만 해당
행동주의자 및 5% 이상 소유자 4 보유
SEC 서류 13D를 제출한 투자자 — 발행인에 영향을 미치려는 의도로 5% 이상의 실질 소유권(행동주의 지분, 이사회 캠페인, M&A). 각 행은 해당 제출자의 포지션에 대한 가장 최근에 알려진 상태를 보여줍니다.
| 제출자 | 제출됨 | 지분 | 상태 | 목적 | 제출 |
|---|---|---|---|---|---|
| EW HEALTHCARE PARTNERS FUND 2, L.P., EW HEALTHCARE PARTNERS FUND 2-A, L.P., EW Healthcare Partners Fund 2-GP, L.P., EW Healthcare Partners Fund 2-UGP, LLC ×5 제출 서류 | 2026년 6월 9일 | 17.23% | 최초 제출 | — | SEC |
| OrbiMed Advisors LLC, OrbiMed Capital GP IV LLC ×7 제출 서류 | 2024년 10월 25일 | — | 최초 제출 | — | SEC |
| 미공개 보고자 | 2022년 6월 10일 | — | 최초 제출 | — | SEC |
| EW Healthcare Partners 2, L.P., EW Healthcare Partners Fund 2-A, L.P., EW Healthcare Partners Fund 2-UGP, LLC, EW Healthcare Partners Fund 2 GP, L.P., Martin P. Sutter, R. Scott Barry, Ronald Eastman, Petri Vainio ×4 제출 서류 | 2022년 6월 1일 | — | 최초 제출 | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF 보유 현황 2 ETF 보유
가중치는 직접적인 주식 보유(N-PORT)만 반영합니다. 레버리지 또는 파생 상품 기반 펀드는 표시되지 않은 추가 스왑 노출을 보유할 수 있습니다.